Stockreport

Tenaya Therapeutics Announces Pricing of Public Offering

Tenaya Therapeutics, Inc.  (TNYA) 
PDF SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to disco [Read more]